skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon


Pharmaprojects | Pharma intelligence




  • 開発企業、ライセンス企業
  • 適応症
  • 開発段階
  • ターゲット、作用機序
  • 投与経路



  • 薬効分類
  • 希少疾患
  • ドラッグデリバリーシステム
  • 希少疾病用医薬品指定
  • 迅速承認制度


  • 前臨床もしくは臨床段階で競合する企業・医薬品は?
  • 有効な治療法が確立されていない領域で、もっとも投資効率が高いものは?
  • 世界的に承認されて販売されている医薬品に関して、まだ上市されていない国は?
  • 開発に失敗した要因は何か?
  • ライセンスインできる医薬品候補化合物は?
  • 特定の疾患領域での開発動向を参考にして、自社品の優先順位を見直せないか?
  • 医薬品開発において特定の疾患領域での失敗確率は?
  • 中期的に開発戦略に影響を与えそうな競合薬は?・


Pharmaprojectsのシニアディレクター・Ian Lloydが、毎年恒例の業界年次レポートPharma R&D Annual Reviewに基づいて講演を行いました(2018/02/21・東京)



  • HBW Insight : コンシューマーヘルスケア産業のニュース

    EU Coronavirus Situation 'Evolving Very Rapidly' Says AESGP

    In response to the outbreak of the Covid-19 pandemic in Europe, the region's self-care industry is working hard to keep shelves stocked with crucial OTC medicines and food supplements, according to the AESGP.

    Topic Coronavirus

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Covid-19 Disrupting Supply Chains Short-Term, Could Spark Long-Term Procurement Shifts

    UNPA anticipates supplies of a ‘significant number’ of China-sourced supplement ingredients will be ‘critical’ by late April as Covid-19 disrupts shipments. During a recent webinar, UNPA CEO Loren Israelsen said he expects disruptions to continue until at least mid-year.

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Coronavirus Disruption Likely In Supply Chain, Stockpiling Spikes Consumer Health Sales

    Hand sanitizer, vitamin, energy drink, first-aid kis and medical face mask sales soar globally as consumers fearing spread of the coronavirus stockpile food and other essentials, a Nielsen report shows. FDA says outbreak could lead to interruptions in drug and medical device supplies; agency has not addressed consumer health supplies specifically, and industry is increasingly concerned with availability.

    Topic Coronavirus

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Coronavirus Slams US Consumer Health Industry Event Schedules, FDA Meetings, Inspections

    In addition to postponing NDAC meeting on food handler antiseptic drug products, FDA is suspending most inspections of foreign manufacturing facilities through April. Latest consumer health industry conferences cancelled or postponed are Consumer Healthcare Product Association and Informa Markets events.

    Topic Coronavirus

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Supplement Industry Summit Postponed, But Sales Jump As Consumers Respond To Covid-19

    Dietary Supplements Regulatory Summit scheduled for 27 May in Washington is postponed. Even as supplies from China are slowed or interrupted due to Covid-19, though, sales of some consumer health products jump as consumers respond to the public health threat.

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Bogus Coronavirus Claims For Silver, Essential Oils, Herbalist's Tea 'Protocol' Plus A Price Discount


    Obviously unsubstantiated claims on how the products either prevent or cure the virus didn’t escape FDA and FTC's attention -- they warned seven firms attempting to capitalize on consumer fears. They warnings are the “first step” and they plan to enforce action against companies that continue to market products with treatment claims.

    Topic Coronavirus

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    No Plans To Remove CBD Products From Shelves, Says UK Food Regulator


    CBD products already on the UK market are safe for now, as the country's Food Standards Agency says it will not take action while it works out how to implement the new European Union novel food regulations. 

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    OTC Drug Oversight By US FDA Split Among Two Divisions In Reorganization


    CDER Office of New Drugs changes its organization including establishing Office of Nonprescription Drugs and splitting the office into Division of Nonprescription Drug Products I and DNDP II. A Division of Regulatory Operations for Nonprescription Drugs will be comprised of regulatory staff from the ONPD divisions and will report to OND’s regulatory office. Non-clinical ONPD staff will report to the office director.

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Polish Industry Fighting Against Advertising Tax On Supplements

    Advertising dietary supplements in Poland will incur a new tax under proposals from the country's Ministry of Health. While the government claims the motivation is to promote healthy eating choices, industry says supplements have been unfairly linked to poor dietary choices without evidence.

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    OTC Zantac And Private Label Ranitidine Numerous In FDA Recall Updates

    In addition to Sanofi, firms recalling OTC ranitidine products with documentation included in FDA's database updates through 9 January are Amneal Pharmaceuticals, Preferred Pharmaceuticals, which distributed products made by Amneal, and Granules India Ltd.

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Bayer Harnessing Skin Microbiome In New Product Development

    Bayer has teamed up with skin microbiome specialist Azitra to develop consumer health products for a host of conditions. 

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    EU Wellness Market In 2019: The CBD Green Rush

    An interactive timeline of HBW Insight's coverage of the blossoming European CBD market in 2019. The timeline covers the main events of the year beginning with the European Commission's decision to classify CBD as a novel food, and ending on the filing of the first application for a synthetic form of the cannabis-derived ingredient.

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Steripod Bolt-on Deal Extends Perrigo Into Toothbrush And Razor Accessories

    Perrigo's Ranir division purchased the brand, which includes a portfolio of antibacterial toothbrush protectors, children’s products and tongue cleaners, for an undisclosed amount from Bonfit America.

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    'Supplement' on CBD Product Label A Bullseye For US Litigants, Says Attorney

    Two CBD marketers warned by FDA in a recent crackdown are targeted in class action complaints alleging they made unsubstantiated health claims and mislabeled ‘illegal drug’ products as supplements. Complaints are a wake-up call to CBD wellness industry to ensure claims are substantiated, as the class action bar is on the prowl following the agency’s 15 warning letter blast in November.

  • HBW Insight : コンシューマーヘルスケア産業のニュース

    Reckitt Targets UK's Painful 'Tweens' With Double-Strength Nurofen

    Reckitt Benckiser wants to give British parents more pain relief options for their teens and "tweens."





電話:+81 (0)3 6273 4260